Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 5,300 shares, a decline of 22.1% from the May 15th total of 6,800 shares. Based on an average daily trading volume, of 1,600 shares, the short-interest ratio is currently 3.3 days.

Revolution Medicines Trading Down 14.0 %

NASDAQ:RVMDW traded down $0.02 during mid-day trading on Friday, hitting $0.12. The stock had a trading volume of 648 shares, compared to its average volume of 6,920. Revolution Medicines has a 52 week low of $0.03 and a 52 week high of $1.05. The company has a 50 day simple moving average of $0.22 and a 200-day simple moving average of $0.24.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.